ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / FundiShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerBTEC(USD) LSE
ETF TickerBTEK(GBP) LSE
ETF Ticker2B70(EUR) F
ETF Ticker2B70.DE(EUR) CXE
ETF TickerBTEC.LS(USD) CXE
ETF TickerBTEK.LS(GBP) CXE
ETF TickerBTEC.L(GBP) LSE
ETF TickerBTEK.L(GBP) LSE

Holdings detail for NUVL

Stock NameNuvalent Inc
TickerNUVL(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS6707031075

Show aggregate NUVL holdings

News associated with NUVL

Nuvalent, Inc. (NASDAQ:NUVL) Receives Consensus Rating of “Buy” from Analysts
Nuvalent, Inc. (NASDAQ:NUVL – Get Free Report) has earned an average recommendation of “Buy” from the eleven ratings firms that are covering the company, Marketbeat Ratings reports. Ten investment analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 1-year target price among […] - 2025-08-29 02:14:49
Piper Sandler Begins Coverage on Nuvalent (NASDAQ:NUVL)
Equities research analysts at Piper Sandler initiated coverage on shares of Nuvalent (NASDAQ:NUVL – Get Free Report) in a note issued to investors on Tuesday, MarketBeat.com reports. The brokerage set an “overweight” rating and a $112.00 price target on the stock. Piper Sandler’s price target indicates a potential upside of 52.92% from the stock’s previous […] - 2025-08-21 04:24:45
Nuvalent, Inc. (NASDAQ:NUVL) Shares Sold by Envestnet Asset Management Inc.
Envestnet Asset Management Inc. trimmed its holdings in shares of Nuvalent, Inc. (NASDAQ:NUVL – Free Report) by 2.3% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 6,520 shares of the company’s stock after selling 153 shares during the period. Envestnet Asset Management Inc.’s holdings in Nuvalent were worth $462,000 as of its most […] - 2025-08-07 05:02:59
Universal Beteiligungs und Servicegesellschaft mbH Sells 11,308 Shares of Nuvalent, Inc. (NASDAQ:NUVL)
Universal Beteiligungs und Servicegesellschaft mbH cut its stake in Nuvalent, Inc. (NASDAQ:NUVL – Free Report) by 20.0% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 45,255 shares of the company’s stock after selling 11,308 shares during the quarter. Universal Beteiligungs und […] - 2025-07-29 05:26:54
Head to Head Analysis: Nuvalent (NASDAQ:NUVL) vs. OnKure Therapeutics (NASDAQ:OKUR)
OnKure Therapeutics (NASDAQ:OKUR – Get Free Report) and Nuvalent (NASDAQ:NUVL – Get Free Report) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, earnings, dividends, valuation, profitability and analyst recommendations. Analyst Ratings This is a breakdown of recent recommendations […] - 2025-07-25 05:56:58
Nuvalent (NASDAQ:NUVL) Given “Outperform” Rating at Wedbush
Wedbush reiterated their outperform rating on shares of Nuvalent (NASDAQ:NUVL – Free Report) in a research report sent to investors on Monday,RTT News reports. The brokerage currently has a $115.00 price target on the stock. NUVL has been the subject of a number of other reports. HC Wainwright reiterated a “buy” rating and set a […] - 2025-07-22 07:10:52
Henry E. Pelish Sells 5,500 Shares of Nuvalent, Inc. (NASDAQ:NUVL) Stock
Nuvalent, Inc. (NASDAQ:NUVL – Get Free Report) insider Henry E. Pelish sold 5,500 shares of the firm’s stock in a transaction dated Thursday, July 10th. The stock was sold at an average price of $79.98, for a total transaction of $439,890.00. Following the completion of the transaction, the insider owned 60,956 shares in the company, […] - 2025-07-14 05:12:52
The Goldman Sachs Group Upgrades Nuvalent (NASDAQ:NUVL) to Strong-Buy
The Goldman Sachs Group upgraded shares of Nuvalent (NASDAQ:NUVL – Free Report) to a strong-buy rating in a research report report published on Monday morning,Zacks.com reports. A number of other research firms also recently issued reports on NUVL. Leerink Partners increased their price target on shares of Nuvalent from $125.00 to $140.00 and gave the […] - 2025-07-03 03:01:05
HC Wainwright Forecasts Strong Price Appreciation for Nuvalent (NASDAQ:NUVL) Stock
Nuvalent (NASDAQ:NUVL – Get Free Report) had its price target boosted by analysts at HC Wainwright from $110.00 to $130.00 in a report released on Tuesday,Benzinga reports. The firm presently has a “buy” rating on the stock. HC Wainwright’s price target suggests a potential upside of 64.37% from the company’s previous close. Separately, UBS Group […] - 2025-06-26 03:13:07
SG Americas Securities LLC Has $989,000 Holdings in Nuvalent, Inc. (NASDAQ:NUVL)
SG Americas Securities LLC grew its position in Nuvalent, Inc. (NASDAQ:NUVL – Free Report) by 29.2% during the 1st quarter, Holdings Channel.com reports. The firm owned 13,946 shares of the company’s stock after purchasing an additional 3,153 shares during the period. SG Americas Securities LLC’s holdings in Nuvalent were worth $989,000 as of its most […] - 2025-06-18 05:56:50
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Grows Stock Holdings in Nuvalent, Inc. (NASDAQ:NUVL)
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of Nuvalent, Inc. (NASDAQ:NUVL – Free Report) by 4.3% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 31,047 shares of the company’s stock after acquiring an additional 1,273 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.’s holdings in Nuvalent were […] - 2025-05-22 05:52:58
Northern Trust Corp Buys 15,770 Shares of Nuvalent, Inc. (NASDAQ:NUVL)
Northern Trust Corp grew its stake in Nuvalent, Inc. (NASDAQ:NUVL – Free Report) by 4.9% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 335,550 shares of the company’s stock after purchasing an additional 15,770 shares during the period. Northern Trust Corp owned approximately […] - 2025-05-12 05:42:54
First Trust Advisors LP Raises Stake in Nuvalent, Inc. (NASDAQ:NUVL)
First Trust Advisors LP lifted its position in Nuvalent, Inc. (NASDAQ:NUVL – Free Report) by 3.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 44,542 shares of the company’s stock after purchasing an additional 1,685 shares during the period. […] - 2025-05-04 05:30:55
Nuvalent, Inc. (NASDAQ:NUVL) Shares Bought by Commonwealth Equity Services LLC
Commonwealth Equity Services LLC increased its holdings in Nuvalent, Inc. (NASDAQ:NUVL – Free Report) by 13.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,618 shares of the company’s stock after purchasing an additional 309 shares during the period. […] - 2025-04-11 04:28:50
Sei Investments Co. Has $549,000 Stock Holdings in Nuvalent, Inc. (NASDAQ:NUVL)
Sei Investments Co. trimmed its position in Nuvalent, Inc. (NASDAQ:NUVL – Free Report) by 44.6% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 7,016 shares of the company’s stock after selling 5,659 shares during the period. Sei Investments Co.’s holdings in Nuvalent were worth $549,000 as of its most recent filing with […] - 2025-04-10 04:18:52
Corebridge Financial Inc. Decreases Stake in Nuvalent, Inc. (NASDAQ:NUVL)
Corebridge Financial Inc. lessened its position in shares of Nuvalent, Inc. (NASDAQ:NUVL – Free Report) by 5.7% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,472 shares of the company’s stock after selling 1,051 shares during the quarter. Corebridge Financial Inc.’s […] - 2025-04-04 05:41:03
US Bancorp DE Makes New $90,000 Investment in Nuvalent, Inc. (NASDAQ:NUVL)
US Bancorp DE acquired a new stake in Nuvalent, Inc. (NASDAQ:NUVL – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 1,156 shares of the company’s stock, valued at approximately $90,000. A number of other hedge funds have also modified […] - 2025-03-18 05:12:56
Nuvalent, Inc. (NASDAQ:NUVL) Holdings Lifted by abrdn plc
abrdn plc raised its position in Nuvalent, Inc. (NASDAQ:NUVL – Free Report) by 19.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 56,701 shares of the company’s stock after purchasing an additional 9,241 shares during the quarter. abrdn plc owned about 0.08% of Nuvalent […] - 2025-02-10 16:42:58

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) NUVL holdings

DateNumber of NUVL Shares HeldBase Market Value of NUVL SharesLocal Market Value of NUVL SharesChange in NUVL Shares HeldChange in NUVL Base ValueCurrent Price per NUVL Share HeldPrevious Price per NUVL Share Held
2025-12-18 (Thursday)49,222USD 4,991,603NUVL holding increased by 7875USD 4,991,6030USD 7,875 USD 101.41 USD 101.25
2025-12-17 (Wednesday)49,222NUVL holding decreased by -560USD 4,983,728NUVL holding decreased by -125399USD 4,983,728-560USD -125,399 USD 101.25 USD 102.63
2025-12-16 (Tuesday)49,782NUVL holding decreased by -112USD 5,109,127NUVL holding decreased by -128246USD 5,109,127-112USD -128,246 USD 102.63 USD 104.97
2025-12-15 (Monday)49,894NUVL holding increased by 224USD 5,237,373NUVL holding increased by 31957USD 5,237,373224USD 31,957 USD 104.97 USD 104.8
2025-12-12 (Friday)49,670USD 5,205,416NUVL holding decreased by -55134USD 5,205,4160USD -55,134 USD 104.8 USD 105.91
2025-12-11 (Thursday)49,670NUVL holding increased by 733USD 5,260,550NUVL holding increased by 85952USD 5,260,550733USD 85,952 USD 105.91 USD 105.74
2025-12-10 (Wednesday)48,937USD 5,174,598NUVL holding increased by 31809USD 5,174,5980USD 31,809 USD 105.74 USD 105.09
2025-12-09 (Tuesday)48,937USD 5,142,789NUVL holding decreased by -136045USD 5,142,7890USD -136,045 USD 105.09 USD 107.87
2025-12-08 (Monday)48,937USD 5,278,834NUVL holding decreased by -84661USD 5,278,8340USD -84,661 USD 107.87 USD 109.6
2025-12-05 (Friday)48,937USD 5,363,495NUVL holding increased by 134087USD 5,363,4950USD 134,087 USD 109.6 USD 106.86
2025-12-04 (Thursday)48,937NUVL holding increased by 2220USD 5,229,408NUVL holding increased by 235361USD 5,229,4082,220USD 235,361 USD 106.86 USD 106.9
2025-12-03 (Wednesday)46,717USD 4,994,047NUVL holding increased by 90631USD 4,994,0470USD 90,631 USD 106.9 USD 104.96
2025-12-02 (Tuesday)46,717NUVL holding increased by 1665USD 4,903,416NUVL holding increased by 108982USD 4,903,4161,665USD 108,982 USD 104.96 USD 106.42
2025-12-01 (Monday)45,052USD 4,794,434NUVL holding decreased by -132002USD 4,794,4340USD -132,002 USD 106.42 USD 109.35
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of NUVL by Blackrock for IE00BYXG2H39

Show aggregate share trades of NUVL

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-12-17SELL-560103.385100.925 101.171USD -56,656 83.99 Loss of -9,619 on sale
2025-12-16SELL-112104.710101.695 101.996USD -11,424 83.91 Loss of -2,026 on sale
2025-12-15BUY224106.145103.680 103.926USD 23,280 83.82
2025-12-11BUY733107.990105.500 105.749USD 77,514 83.62
2025-12-04BUY2,220 106.860* 83.08
2025-12-02BUY1,665106.980103.510 103.857USD 172,922 82.87
2025-11-28BUY111109.455107.190 107.417USD 11,923 82.63
2025-11-26BUY333110.925107.790 108.104USD 35,998 82.38
2025-11-26BUY333110.925107.790 108.104USD 35,998 82.38
2025-11-25BUY555111.240107.960 108.288USD 60,100 82.25
2025-11-24BUY111112.110106.860 107.385USD 11,920 82.12
2025-11-20SELL-444 108.010* 81.88 Profit of 36,353 on sale
2025-11-19BUY111 107.130* 81.75
2025-11-18BUY666 104.240* 81.64
2025-11-17BUY222112.53093.300 95.223USD 21,140 81.51
2025-11-14BUY11198.15093.050 93.560USD 10,385 81.44
2025-11-12BUY11199.12096.490 96.753USD 10,740 81.29
2025-11-10BUY11095.22591.150 91.558USD 10,071 81.16
2025-11-06BUY11096.08591.590 92.039USD 10,124 81.02
2025-11-04BUY11193.57590.500 90.807USD 10,080 80.91
2025-10-30BUY555104.90096.165 97.039USD 53,856 80.66
2025-10-29BUY222102.970103.920 103.825USD 23,049 80.55
2025-10-22SELL-44490.88097.940 97.234USD -43,172 80.16 Loss of -7,581 on sale
2025-10-20BUY22297.97098.540 98.483USD 21,863 79.97
2025-10-17BUY55492.52092.900 92.862USD 51,446 79.90
2025-10-15BUY88089.64090.230 90.171USD 79,350 79.85
2025-10-03BUY77084.22084.788 84.731USD 65,243 79.80
2025-10-02BUY11083.86084.060 84.040USD 9,244 79.77
2025-09-30BUY22086.48086.755 86.727USD 19,080 79.72
2025-09-26BUY22081.39081.780 81.741USD 17,983 79.68
2025-09-25BUY22077.52079.610 79.401USD 17,468 79.69
2025-09-24SELL-1,70779.54082.810 82.483USD -140,798 79.69 Loss of -4,761 on sale
2025-09-18BUY11480.96081.670 81.599USD 9,302 79.69
2025-09-17BUY34578.64081.275 81.012USD 27,949 79.69
2025-08-20SELL-46073.24074.880 74.716USD -34,369 79.79 Profit of 2,336 on sale
2025-07-30BUY46079.54082.100 81.844USD 37,648 79.89
2025-07-17SELL-23085.69086.830 86.716USD -19,945 79.76 Loss of -1,599 on sale
2025-07-16BUY41685.45085.585 85.571USD 35,598 79.73
2025-07-11SELL-90480.93082.290 82.154USD -74,267 79.66 Loss of -2,252 on sale
2025-07-07BUY33977.93080.060 79.847USD 27,068 79.65
2025-07-02BUY6,21580.50080.895 80.855USD 502,517 79.64
2025-06-20BUY1,06175.00076.243 76.119USD 80,762 79.67
2025-06-11BUY22076.91079.900 79.601USD 17,512 79.83
2025-06-10BUY22079.46079.680 79.658USD 17,525 79.84
2025-06-04SELL-11076.82078.820 78.620USD -8,648 79.92 Profit of 143 on sale
2025-04-23BUY11072.71074.280 74.123USD 8,154 81.88
2025-04-10SELL-88061.99065.875 65.487USD -57,628 83.15 Profit of 15,543 on sale
2025-04-08SELL-11059.32068.445 67.532USD -7,429 83.63 Profit of 1,771 on sale
2025-04-07SELL-11064.68066.640 66.444USD -7,309 83.85 Profit of 1,915 on sale
2025-04-04SELL-55065.74068.035 67.806USD -37,293 84.07 Profit of 8,944 on sale
2025-04-01BUY96268.00072.610 72.149USD 69,407 84.43
2025-03-31SELL-32470.92072.850 72.657USD -23,541 84.59 Profit of 3,866 on sale
2025-03-21BUY1,41977.96078.770 78.689USD 111,660 85.34
2025-03-14SELL-1,64877.01078.230 78.108USD -128,722 85.91 Profit of 12,862 on sale
2025-03-07SELL-20671.07073.210 72.996USD -15,037 87.03 Profit of 2,891 on sale
2025-03-04SELL-10371.61072.530 72.438USD -7,461 87.74 Profit of 1,576 on sale
2025-02-25BUY20675.89078.100 77.879USD 16,043 88.86
2025-02-19SELL-10380.26080.390 80.377USD -8,279 89.51 Profit of 941 on sale
2025-02-13BUY30980.95084.800 84.415USD 26,084 90.35
2025-02-12BUY10381.24082.440 82.320USD 8,479 90.54
2025-02-11BUY41282.90083.800 83.710USD 34,489 90.70
2025-01-02BUY30879.99080.770 80.692USD 24,853 93.09
2024-12-30SELL-51077.87080.720 80.435USD -41,022 93.55 Profit of 6,689 on sale
2024-11-18SELL-1,53087.69089.040 88.905USD -136,025 93.08 Profit of 6,390 on sale
2024-11-08SELL-10295.42095.600 95.582USD -9,749 93.06 Loss of -257 on sale
2024-10-30BUY31190.24091.090 91.005USD 28,303 95.05
2024-10-21SELL-101101.165104.440 104.113USD -10,515 0.00 Loss of -10,515 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of NUVL

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-1971,180091,14478.1%
2025-09-1852,005071,96172.3%
2025-09-1791,4140108,41084.3%
2025-09-1662,3632579,41278.5%
2025-09-15144,55911,459178,64380.9%
2025-09-1296,0060146,68665.5%
2025-09-11140,3530179,91778.0%
2025-09-10115,8250131,86487.8%
2025-09-0965,3844984,35377.5%
2025-09-08151,430100169,01089.6%
2025-09-0584,73740126,84066.8%
2025-09-04118,29750143,87582.2%
2025-09-03172,398400368,58746.8%
2025-09-02139,90219264,90652.8%
2025-08-29122,4690169,21572.4%
2025-08-2893,0764,542145,18964.1%
2025-08-2743,710058,03875.3%
2025-08-2698,6270111,83988.2%
2025-08-2550,5153,50860,74483.2%
2025-08-2271,646093,45976.7%
2025-08-21119,5900146,37281.7%
2025-08-20142,0570157,45590.2%
2025-08-19103,3670121,90984.8%
2025-08-18148,6151,340195,87675.9%
2025-08-15121,56513,917142,96785.0%
2025-08-1481,547090,24990.4%
2025-08-1379,956091,95387.0%
2025-08-1279,180093,30784.9%
2025-08-11208,7430331,55863.0%
2025-08-08157,0444499,99031.4%
2025-08-07183,21070283,21964.7%
2025-08-0679,040117148,18653.3%
2025-08-0581,6980187,48743.6%
2025-08-0488,28982158,46755.7%
2025-08-0179,833663104,43276.4%
2025-07-3199,8820130,17576.7%
2025-07-3064,1752,60085,94274.7%
2025-07-2972,0772158,00845.6%
2025-07-28129,5802,165229,24056.5%
2025-07-25269,9880645,79741.8%
2025-07-2458,732216133,05244.1%
2025-07-2340,2962,71184,79047.5%
2025-07-2268,0820106,34164.0%
2025-07-2169,19595116,54959.4%
2025-07-1877,99045135,27557.7%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy